Abstract
Deoxybostrycin (1) is an anthraquinone compound derived from the marine mangrove fungus Nigrospora sp. No. 1403 and has potential to be a lead for new drugs because of its various biological properties. A series of new derivatives (2- 22) of deoxybostrycin were synthesized. The in vitro cytotoxicity of all the new compounds was tested against MDA-MB-435, HepG2 and HCT-116 cancer cell lines. Most of the compounds exhibit strong cytotoxicity with IC50 values ranging from 0.62 to 10 μM. Compounds 19, 21 display comparable cytotoxicity against MDA-MB-435 to epirubicin, the positive control. The primary screening results indicate that the deoxybostrycin derivatives might be a valuable source of new potent anticancer drug candidates. © 2012 by the authors.
Author supplied keywords
Cite
CITATION STYLE
Chen, H., Zhu, X., Zhong, L. L., Yang, B., Li, J., Wu, J. H., … She, Z. G. (2012). Synthesis and antitumor activities of derivatives of the marine mangrove fungal metabolite deoxybostrycin. Marine Drugs, 10(12), 2715–2728. https://doi.org/10.3390/md10122715
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.